首页> 美国卫生研究院文献>CEN Case Reports >Usefulness of a pleuroperitoneal shunt for treatment of refractory pleural effusion in a patient receiving maintenance hemodialysis
【2h】

Usefulness of a pleuroperitoneal shunt for treatment of refractory pleural effusion in a patient receiving maintenance hemodialysis

机译:腹膜分流在接受维持性血液透析的患者中治疗难治性胸腔积液的有用性

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Refractory pleural effusion can be a life-threatening complication in patients receiving maintenance hemodialysis. We report successful treatment of refractory pleural effusion using a Denver® pleuroperitoneal shunt in one such patient. A 54-year-old Japanese man, who had previously undergone left nephrectomy, was admitted urgently to our department because of a high C-reactive protein (CRP) level, right pleural effusion, and right renal abscess. Because antibiotics proved ineffective and his general state was deteriorating, he underwent emergency insertion of a thoracic drainage tube and nephrectomy, and hemodialysis was started. Although his general state improved slowly thereafter, the pleural effusion, which was unilateral and transudative, remained refractory and therefore he needed to be on oxygenation. To control the massive pleural effusion, a pleuroperitoneal shunt was inserted. Thereafter, his respiratory condition became stable without oxygenation and he was discharged. His general condition has since been well. Although pleural effusion is a common complication of maintenance hemodialysis, few reports have documented the use of pleuroperitoneal shunt to control refractory pleural effusion. Pleuroperitoneal shunt has been advocated as an effective and low-morbidity treatment for refractory pleural effusion, and its use for some patients with recurrent pleural effusion has also been reported, without any severe complications. In the present case, pleuroperitoneal shunt improved the patient’s quality of life sufficiently to allow him to be discharged home without oxygenation. Pleuroperitoneal shunt should be considered a useful treatment option for hemodialysis patients with refractory pleural effusion.
机译:难治性胸腔积液在接受维持性血液透析的患者中可能是危及生命的并发症。我们报道了在一名这样的患者中使用Denver®胸腹膜分流术成功治疗难治性胸腔积液。一名曾经接受左肾切除术的54岁日本男子因C反应蛋白(CRP)水平高,右胸腔积液和右肾脓肿而紧急入院。由于证明抗生素无效并且他的总体状况恶化,他接受了紧急插入胸腔引流管和肾切除术的工作,并开始了血液透析。尽管此后他的总体状态缓慢改善,但单侧渗出的胸腔积液仍难治,因此需要进行充氧。为了控制大量的胸腔积液,插入了胸膜腹腔分流器。此后,他的呼吸情况变得稳定,没有充氧,他出院了。从那以后,他的总体状况一直很好。尽管胸腔积液是维持性血液透析的常见并发症,但很少有文献报道使用胸腹膜分流术来控制难治性胸腔积液。胸膜分流术一直被认为是难治性胸腔积液的一种有效且低发病率的治疗方法,并且已经报道了将其用于某些复发性胸腔积液患者,没有任何严重的并发症。在目前的情况下,腹膜腹腔分流术可充分改善患者的生活质量,使患者无需氧合即可出院。对于难治性胸腔积液的血液透析患者,应考虑采用胸膜分流术。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号